Free Newsletter
California's stem cell boom spurs research bonanza
As head of the California Institute of Regenerative Medicine, Dr. Alan Trounson is pushing hard to inspire a medical revolution in the space of a single decade. The Wall Street Journal looks at the rapidly changing research field, and how California's $3 billion commitment to stem cell research over 10 years has already triggered a $1.2 billion boom in spending on new research facilities.
The institute says the initial burst of investment has already drawn 24 top scientists to the state with 33 younger researchers joining the migration to California. But the new facilities being built will house 2,200 researchers, the equivalent of the entire membership of the International Society for Stem Cell Research. Now Trounson is preparing to fund disease teams at a cost of $20 million each that can advance therapies to the clinic in five years. The institute is considering a new loan fund that would give the state a stake in commercial successes.
- read the article from the Wall Street Journal
Related Articles:
Stem cell agency names president
Calif. stem cell chief questioned in research probe
California grants ignite a boom of lab construction
California delivers millions for stem cell research
California--Top Five Regions Targeting Biotech, 2008
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: